Damora Therapeutics, Inc.
Ownership
Ownership Structure
Who owns Damora Therapeutics, Inc. (DMRA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 67.1% of the shares are freely tradable; institutional investors hold 102.3%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 14.96 | 9,232,979 | +2.1 | 06/30/2026 |
| venBio Select Advisor LLC | 6.13 | 3,783,000 | +0.0 | 06/30/2026 |
| BlackRock Inc | 5.12 | 3,162,068 | +1,321.6 | 06/30/2026 |
| Viking Global Investors LP | 3.74 | 2,311,082 | +0.0 | 06/30/2026 |
| Remedium Capital Partners, LLC | 3.31 | 2,045,473 | +0.0 | 06/30/2026 |
| COMMODORE CAPITAL LP | 3.14 | 1,939,000 | +0.0 | 06/30/2026 |
| BRAIDWELL LP | 2.62 | 1,620,377 | +81.1 | 06/30/2026 |
| Bellevue Group AG | 2.62 | 1,618,846 | -29.6 | 06/30/2026 |
| State Street Corp | 2.50 | 1,545,500 | +740.3 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Growth Company Fund | 2.96 | 1,835,051 | +0.5 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Jarrett Jennifer | Director, President and CEO | 512,500 | 11,070,000 $ | Sep 25, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 25, 2026 | Jarrett Jennifer | Director, President and CEO | Buy | 12,500 | 20.23 | 252,875 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.